BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 28913674)

  • 1. Prognostic significance of corticotroph staining in radiosurgery for non-functioning pituitary adenomas: a multicenter study.
    Cohen-Inbar O; Xu Z; Lee CC; Wu CC; Chytka T; Silva D; Sharma M; Radwan H; Grills IS; Nguyen B; Siddiqui Z; Mathieu D; Iorio-Morin C; Wolf A; Cifarelli CP; Cifarelli DT; Lunsford LD; Kondziolka D; Sheehan JP
    J Neurooncol; 2017 Oct; 135(1):67-74. PubMed ID: 28913674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Silent corticotroph adenomas after stereotactic radiosurgery: a case-control study.
    Xu Z; Ellis S; Lee CC; Starke RM; Schlesinger D; Lee Vance M; Lopes MB; Sheehan J
    Int J Radiat Oncol Biol Phys; 2014 Nov; 90(4):903-10. PubMed ID: 25216855
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypopituitarism after stereotactic radiosurgery for pituitary adenomas.
    Xu Z; Lee Vance M; Schlesinger D; Sheehan JP
    Neurosurgery; 2013 Apr; 72(4):630-7; 636-7. PubMed ID: 23277375
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of higher dose stereotactic radiosurgery for functional pituitary adenomas: a preliminary report.
    Grant RA; Whicker M; Lleva R; Knisely JP; Inzucchi SE; Chiang VL
    World Neurosurg; 2014; 82(1-2):195-201. PubMed ID: 23385448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gamma Knife radiosurgery for the management of nonfunctioning pituitary adenomas: a multicenter study.
    Sheehan JP; Starke RM; Mathieu D; Young B; Sneed PK; Chiang VL; Lee JY; Kano H; Park KJ; Niranjan A; Kondziolka D; Barnett GH; Rush S; Golfinos JG; Lunsford LD
    J Neurosurg; 2013 Aug; 119(2):446-56. PubMed ID: 23621595
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Initial Gamma Knife radiosurgery for nonfunctioning pituitary adenomas.
    Lee CC; Kano H; Yang HC; Xu Z; Yen CP; Chung WY; Pan DH; Lunsford LD; Sheehan JP
    J Neurosurg; 2014 Mar; 120(3):647-54. PubMed ID: 24405068
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Silent corticotroph pituitary adenomas: clinical characteristics, long-term outcomes, and management of disease recurrence.
    Strickland BA; Shahrestani S; Briggs RG; Jackanich A; Tavakol S; Hurth K; Shiroishi MS; Liu CJ; Carmichael JD; Weiss M; Zada G
    J Neurosurg; 2021 May; 135(6):1706-1713. PubMed ID: 33962375
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Silent corticotroph adenomas.
    Ben-Shlomo A; Cooper O
    Pituitary; 2018 Apr; 21(2):183-193. PubMed ID: 29344907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Silent Corticotroph Staining Pituitary Neuroendocrine Tumors: Prognostic Significance in Radiosurgery.
    Maragkos GA; Mantziaris G; Pikis S; Chytka T; Liscak R; Peker S; Samanci Y; Bindal SK; Niranjan A; Lunsford LD; Kaur R; Madan R; Tripathi M; Pangal DJ; Strickland BA; Zada G; Langlois AM; Mathieu D; Warnick RE; Patel S; Minier Z; Speckter H; Kondziolka D; Lee CC; Vance ML; Sheehan JP
    Neurosurgery; 2023 Dec; 93(6):1407-1414. PubMed ID: 37966247
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypopituitarism after gamma knife radiosurgery for pituitary adenoma.
    Zibar Tomšić K; Dušek T; Kraljević I; Heinrich Z; Solak M; Vučinović A; Ozretić D; Mihailović Marasanov S; Hršak H; Kaštelan D
    Endocr Res; 2017 Nov; 42(4):318-324. PubMed ID: 28537768
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of Crooke's changes in recurrence and remission after gamma knife radiosurgery.
    Cordeiro D; Xu Z; Nasser M; Lopes B; Vance ML; Sheehan J
    J Neurooncol; 2019 Mar; 142(1):171-181. PubMed ID: 30607704
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dose to neuroanatomical structures surrounding pituitary adenomas and the effect of stereotactic radiosurgery on neuroendocrine function: an international multicenter study.
    Pomeraniec IJ; Xu Z; Lee CC; Yang HC; Chytka T; Liscak R; Martinez-Alvarez R; Martinez-Moreno N; Attuati L; Picozzi P; Kondziolka D; Mureb M; Bernstein K; Mathieu D; Maillet M; Ogino A; Long H; Kano H; Lunsford LD; Zacharia BE; Mau C; Tuanquin LC; Cifarelli C; Arsanious D; Hack J; Warnick RE; Strickland BA; Zada G; Chang EL; Speckter H; Patel S; Ding D; Sheehan D; Sheehan K; Kvint S; Buch LY; Haber AR; Shteinhart J; Vance ML; Sheehan JP
    J Neurosurg; 2022 Mar; 136(3):813-821. PubMed ID: 34560630
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The efficacy of fractionated radiotherapy and stereotactic radiosurgery for pituitary adenomas: long-term results of 125 consecutive patients treated in a single institution.
    Kong DS; Lee JI; Lim DH; Kim KW; Shin HJ; Nam DH; Park K; Kim JH
    Cancer; 2007 Aug; 110(4):854-60. PubMed ID: 17599761
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gamma Knife surgery for patients with nonfunctioning pituitary macroadenomas: predictors of tumor control, neurological deficits, and hypopituitarism.
    Starke RM; Williams BJ; Jane JA; Sheehan JP
    J Neurosurg; 2012 Jul; 117(1):129-35. PubMed ID: 22577749
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical profile of silent growth hormone pituitary adenomas; higher recurrence rate compared to silent gonadotroph pituitary tumors, a large single center experience.
    Langlois F; Lim DST; Varlamov E; Yedinak CG; Cetas JS; McCartney S; Dogan A; Fleseriu M
    Endocrine; 2017 Dec; 58(3):528-534. PubMed ID: 29043561
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypopituitarism after Gamma Knife surgery for postoperative nonfunctioning pituitary adenoma.
    Oh JW; Sung KS; Moon JH; Kim EH; Chang WS; Jung HH; Chang JW; Park YG; Kim SH; Chang JH
    J Neurosurg; 2018 Dec; 129(Suppl1):47-54. PubMed ID: 30544293
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pediatric silent corticotroph pituitary adenoma and role for proton therapy: case report.
    Prendergast N; Aldana PR; Rotondo RL; Torres-Santiago L; Beier AD
    J Neurosurg Pediatr; 2018 Nov; 23(2):214-218. PubMed ID: 30497138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stereotactic Radiosurgery for Cushing Disease: Results of an International, Multicenter Study.
    Mehta GU; Ding D; Patibandla MR; Kano H; Sisterson N; Su YH; Krsek M; Nabeel AM; El-Shehaby A; Kareem KA; Martinez-Moreno N; Mathieu D; McShane B; Blas K; Kondziolka D; Grills I; Lee JY; Martinez-Alvarez R; Reda WA; Liscak R; Lee CC; Lunsford LD; Vance ML; Sheehan JP
    J Clin Endocrinol Metab; 2017 Nov; 102(11):4284-4291. PubMed ID: 28938462
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complications after transsphenoidal surgery for patients with Cushing's disease and silent corticotroph adenomas.
    Smith TR; Hulou MM; Huang KT; Nery B; de Moura SM; Cote DJ; Laws ER
    Neurosurg Focus; 2015 Feb; 38(2):E12. PubMed ID: 25639314
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Silent corticotroph adenomas have unique recurrence characteristics compared with other nonfunctioning pituitary adenomas.
    Cho HY; Cho SW; Kim SW; Shin CS; Park KS; Kim SY
    Clin Endocrinol (Oxf); 2010 May; 72(5):648-53. PubMed ID: 19650787
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.